The Sergievsky Award (“Sergievsky Award”) provides support for physicians and scientists who are conducting clinical research that addresses issues affecting medically underserved individuals with epilepsy or seizures or other epilepsy related aspects of health equity. The intention of this award is to facilitate the launch of individuals into a career of leadership in academic clinical research. Proposals are welcomed across the spectrum of epilepsy research. The applicant should specify how the project addresses the main goals of the award.
The Sergievsky Award provides two years of support, $75,000 per year (total award $150,000), as well as two years of complimentary registration to the AES Annual Meeting and complimentary AES membership. The second year of funding and benefits are contingent on progress in the first year. The number of awards granted each year is contingent upon available funds.
The awardee will also be invited and strongly encouraged to engage with the AES community, with the objective of completing at least one of the identified activities during their award period. These may include: an opportunity to present scholarship at the annual meeting, consideration of a publication of commentary or results of research in Epilepsy Currents, and service within AES during the award term and beyond. AES service will be tailored to the candidate’s goals and may include participation on the Early Career Grant Committee, Epilepsy Currents contributing editor, AES DEI Committee, or another AES committee aligned with career goals. The awardee will also be invited to participate in the annual AES leadership training program. Normal review and acceptance processes will be followed where applicable
APPLICATION DEADLINES AND AWARD DATES
September 2025: Application submission opens through ProposalCentral
January 22, 2026: Full proposals due
By May 31, 2026: Award notifications sent out
July 1, 2026: Earliest award start date. May be delayed up to 3 months
June 30, 2027: Year 1 progress report due
July 1, 2027: Year 2 start date
June 30, 2028: Award end
AES only funds work that directly advances epilepsy research, including:
Mechanisms of seizure generation/spread
Epileptogenesis
Models of childhood epilepsies
Precision therapeutics
SUDEP and comorbidities
Diagnostics, imaging, computational neuroscience
Translational pathways toward clinical application
Predictor: Your project must be explicitly and centrally about epilepsy, not broadly neuroscience.
AES awards are sharply matched to career stage and purpose:
• Predoctoral Research Fellowships
Must show strong mentorship, a focused epilepsy project, and training plan.
• Postdoctoral Fellowships
Require a robust mentor, evidence of productivity (first-author papers), and feasibility of independence.
• Early Career Research Grants
Applicants must be faculty within ~5 years of first appointment.
Reviewers look for clear independence, preliminary data, and a trajectory toward R01/NIH-style funding.
• Seed Grants
Designed to generate preliminary data for larger NIH/CDC/NSF grants.
High-risk/high-yield pilot aims are valued.
• Research & Training Fellowships / Infrastructure awards
Focus on developing expertise and building epilepsy research capacity.
Predictor: Choose the mechanism that exactly matches your career stage, independence level, and project maturity.
AES reviewers consistently reward:
Pilot data that supports feasibility
Clear rationale for hypotheses
Evidence that methods are working
A logical next step built on your lab’s strengths
Predictor: Preliminary data—even modest—is often a make-or-break factor.
Especially for pre/postdoctoral and early career awards, reviewers expect:
A senior, active epilepsy investigator as mentor
Dual mentorship (clinical + basic, computational + electrophysiology) when appropriate
Institutional commitment (workspace, equipment, protected time)
Predictor: A powerful mentor + strong institutional environment dramatically boosts success.
Winning AES grants consistently include:
Two or three sharply defined aims
Clear hypotheses
Timelines with realistic milestones
Defined paths to publication
Risk mitigation strategies
Predictor: Reviewers must see that your 1–2 year plans are achievable with the requested funds.
AES places a high value on:
New models and technologies
AI/ML methods for seizure detection or prediction
Novel circuit or synaptic mechanisms
Platform technologies (e.g., optogenetics, viral vectors, neuromodulation)
Translational bridges (from animal → human → clinical feasibility)
Predictor: Innovation must be clearly articulated and tied to improving epilepsy outcomes.
AES places strong emphasis on cultivating future leaders.
Reviewers reward applicants who show:
A sustained interest in epilepsy
A publication record in epilepsy or seizure research
Clear plans to remain in the epilepsy research community
Participation in AES annual meetings and networks
Predictor: Demonstrating a long-term epilepsy research identity increases competitiveness.
High-scoring AES applications:
Are extremely clear and concise
Have a strong “Significance” section explaining how the project addresses an important unmet need
Use compelling, confident but scientifically accurate writing
Are visually clean with logical flow through sections
Predictor: Writing quality directly affects reviewer enthusiasm.
AES increasingly values proposals that:
Study underrepresented or rare epilepsy syndromes
Address health equity
Involve diverse communities in clinical studies
Increase diversity in the research workforce
Predictor: Explicitly addressing D&I strengthens many AES applications.
Not required—but historically correlated with success:
Presenting abstracts at AES
Participating in AES SIGs (Special Interest Groups)
Networking with AES investigators
Involvement in AES mentorship or trainee programs
Predictor: Active AES participation signals commitment and builds reviewer familiarity.
| Success Predictor | Why It Matters |
|---|---|
| Epilepsy-focused research | AES mission alignment |
| Correct award match | Ensures expectations and project fit |
| Preliminary data | Proves feasibility |
| Strong mentorship | Critical for early-career applicants |
| Clear aims & milestones | Helps reviewers trust the plan |
| Innovation + impact | Core review criteria |
| Career commitment to epilepsy | AES invests in future leaders |
| Excellent writing | Increases reviewer enthusiasm |
| Equity and inclusion | Growing priority |
| AES community engagement | Signals seriousness & credibility |
Applicants must:
1. Hold a MD, DO, PhD, PharmD, Doctor of Nursing, or, other professional degree within the appropriate track.
2. Have a job title of clinical fellow, research fellow, clinical instructor, or clinician investigator or assistant professor for clinicians, or equivalent levels of career for nonphysicians in neuropsychology, psychology, pharmacology, nursing, or research. Applicants who are in training at the time of submission (e.g., clinical fellows or similar) must have a position offered as an incoming faculty member. Applicants with appointments at the level of Adjunct Professor or Associate Professor are not eligible, nor are research assistants, graduate or medical students, postdoctoral research fellows, medical residents, permanent government employees, or employees of private industry.
3. Research should focus on clinical research that addresses issues affecting medically underserved people with epilepsy or seizures or related aspects of health equity.
4. Have a defined research plan and access to institutional resources to conduct the proposed project.
5. Be able to devote at least 50% of their professional effort to research. If reduced protected time is deemed necessary by an early career clinical faculty applicant, such requests will be considered on a case-by-case manner and on a competitive basis, provided that such requests do not compromise the training experience and research goals of the applicant’s project. Early career clinical faculty applicants who request reduced effort for this award must include in their application a justification and elaborate on their plans to ensure that the research and training goals of the award will be met.
6. Have a qualified mentor or mentoring team with expertise relevant to the scientific goals of the application and who has a focus on career development.
7. Other support: To qualify as an early career grant applicant, you must meet all of the other eligibility requirements AND be either a new investigator or an at-risk investigator (or both), defined as: a. New investigator (you have received no more than $100k total in extramural grant direct costs as PI in the last 2 years), and/or,
b. At-risk investigator (defined as follows: you have had prior research support as an investigator AND, unless successful in securing a new grant in the current fiscal year, you will have no funding in the following fiscal year).
c. If you have any questions on your eligibility, please email grants@aesnet.org to confirm.
8. Should not have previously received the Susan Spencer Fellowship, an AES Research and Training Fellowship for Clinicians, or a Sergievsky Award.
In addition:
9. Applicants whose research will involve patient care or direct involvement with patients must have completed all relevant clinical training and be licensed to practice at their institution.
10. U.S. citizenship is not required; clinical work or catchment area may lie outside U.S. borders, but primary academic employment of the applicant must be within a U.S. institution.
Sponsor Institute/Organizations: American Epilepsy Society
Sponsor Type: Corporate/Non-Profit
Address: 141 W. Jackson Blvd. Suite 1065 Chicago, IL 60604 Phone: 312-883-3800 Fax: 312-896-5784
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Jan 22, 2026
Jan 22, 2026
$75,000
Affiliation: American Epilepsy Society
Address: 141 W. Jackson Blvd. Suite 1065 Chicago, IL 60604 Phone: 312-883-3800 Fax: 312-896-5784
Website URL: https://aesnet.org/research-funding/early-career/early-career
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.